Pharming Change In Cash from 2010 to 2025

PHAR Stock  USD 8.68  0.14  1.64%   
Pharming Group Change In Cash yearly trend continues to be relatively stable with very little volatility. Change In Cash is likely to grow to about -124.5 M this year. During the period from 2010 to 2025, Pharming Group Change In Cash destribution of quarterly values had r-value of (0.46) from its regression line and median of  1,651,810. View All Fundamentals
 
Change In Cash  
First Reported
2009-03-31
Previous Quarter
-4.8 M
Current Value
13.5 M
Quarterly Volatility
22.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pharming Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharming Group's main balance sheet or income statement drivers, such as Depreciation And Amortization of 19.2 M, Interest Expense of 6.4 M or Selling And Marketing Expenses of 7.4 M, as well as many indicators such as Price To Sales Ratio of 4.16, Dividend Yield of 0.0 or PTB Ratio of 3.92. Pharming financial statements analysis is a perfect complement when working with Pharming Group Valuation or Volatility modules.
  
Check out the analysis of Pharming Group Correlation against competitors.

Latest Pharming Group's Change In Cash Growth Pattern

Below is the plot of the Change In Cash of Pharming Group NV over the last few years. It is Pharming Group's Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharming Group's overall financial position and show how it may be relating to other accounts over time.
Change In Cash10 Years Trend
Slightly volatile
   Change In Cash   
       Timeline  

Pharming Change In Cash Regression Statistics

Arithmetic Mean(12,228,345)
Coefficient Of Variation(557.86)
Mean Deviation45,840,171
Median1,651,810
Standard Deviation68,216,814
Sample Variance4653.5T
Range269.5M
R-Value(0.46)
Mean Square Error3910.3T
R-Squared0.22
Significance0.07
Slope(6,655,246)
Total Sum of Squares69803T

Pharming Change In Cash History

2025-124.5 M
2024-131 M
2023-145.6 M
202215.4 M
20212.6 M
2020123.9 M
2019-14.5 M

About Pharming Group Financial Statements

Pharming Group shareholders use historical fundamental indicators, such as Change In Cash, to determine how well the company is positioned to perform in the future. Although Pharming Group investors may analyze each financial statement separately, they are all interrelated. The changes in Pharming Group's assets and liabilities, for example, are also reflected in the revenues and expenses on on Pharming Group's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Change In Cash-131 M-124.5 M

Additional Tools for Pharming Stock Analysis

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.